Navigation Links
Boston Scientific Receives Exclusive Expanded Indication for Its CRT-Ds
Date:9/16/2010

NATICK, Mass., Sept. 16 /PRNewswire-FirstCall/ -- Boston Scientific Corporation (NYSE: BSX) today announced that the U.S. Food and Drug Administration (FDA) has approved an expanded indication for its cardiac resynchronization therapy defibrillators (CRT-Ds), including the COGNIS® CRT-D.  The exclusive expanded indication is effective immediately and makes Boston Scientific CRT-Ds the only devices approved by the FDA for patients in all New York Heart Association (NYHA) classes of heart failure(1).

The Company's CRT-Ds had previously been approved for NYHA Class III and IV patients.  The expanded indication approves Boston Scientific CRT-Ds for use in high risk(2) NYHA Class I and II patients with Left Bundle Branch Block(3) (LBBB).  These patients accounted for 70 percent of the MADIT-CRT clinical trial population.

"The MADIT-CRT trial demonstrated that Boston Scientific's CRT-Ds reduce death and heart failure events, even for patients without symptoms," said Kenneth Stein, M.D., Senior Vice President and Chief Medical Officer, CRM, for Boston Scientific's Cardiology, Rhythm and Vascular Group.  "Preventing or delaying a first heart failure event in NYHA Class I and II patients with LBBB is critical because these patients are eight times more likely to have a recurring event after their initial event."

In response to a request from the FDA, Boston Scientific worked with the MADIT-CRT Executive Committee to perform further analysis of the trial data to determine if there were additional criteria to identify patients at risk for heart failure.  The Company's analysis showed that LBBB was the best baseline characteristic to differentiate which Class I and II patients would be most likely to benefit from a CRT-D.  MADIT-CRT data demonstrated that patients with LBBB who received CRT-D therapy showed a relative risk reduction of al
'/>"/>

SOURCE Boston Scientific Corporation
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Regado Biosciences to Present at the Stifel Nicolaus Healthcare Conference 2010 on September 16, 2010 in Boston, Massachusetts
2. Boston Millennia Partners Portfolio Company CardioMEMS Signs Equity Investment and Exclusive Option to be Acquired for an Additional $375,000,000
3. Childrens Hospital Boston and Particle Sciences Cooperate on Translational Medicine Efforts
4. Boston Scientifics Womens Health Products Featured in Studies at the Joint Annual Meeting of the International Continence Society and International Urogynecological Association
5. Boston Scientific Launches Neuroform EZ(TM) Stent System in U.S. and Europe
6. Regado Biosciences to Present at the 2010 Wells Fargo Healthcare Conference on June 24, 2010 in Boston, Massachusetts
7. Cumberland Pharmaceuticals to Present at the Wells Fargo Healthcare Conference in Boston on June 23, 2010
8. Boston Scientific Announces Japanese Approval for PROMUS(R) Everolimus-Eluting Coronary Stent System
9. Boston Scientific Announces Settlement of DOJ Investigation Relating to Post-Market Surveys Conducted By Guidant
10. Boston Scientific Announces Election of Nelda Connors to Its Board of Directors
11. Boston Scientific Announces Pricing of $2 Billion of Senior Notes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/27/2015)...  MiMedx Group, Inc. (NASDAQ: MDXG ), ... tissue and patent-protected processes to develop and market ... Surgical, Orthopedic, Spine, Sports Medicine, Ophthalmic and Dental ... multiple inaccuracies in the press release issued by ... rulings from the Patent Trial and Appeal Board ...
(Date:8/27/2015)... the leading innovation partner to companies worldwide , ... and anticipates the creation of over 350 new jobs through ... In 2013, the State of Ohio ... to accelerate adoption of open innovation among Ohio ... revenues. To date over 45 middle market companies have worked ...
(Date:8/27/2015)... 27, 2015  Hill-Rom Holdings, Inc., (NYSE: HRC ... at the Morgan Stanley Global Healthcare Conference on September ... are invited to listen to the live discussion via ... directly at https://cc.talkpoint.com/morg007/091615a_ae/?entity=49_UCJPU8N . A recorded ... after the conclusion of the live event and accessible ...
Breaking Medicine Technology:MiMedx Corrects Inaccuracies In MTF Press Release Regarding The Recent Rulings From The Patent Trial And Appeal Board 2MiMedx Corrects Inaccuracies In MTF Press Release Regarding The Recent Rulings From The Patent Trial And Appeal Board 3MiMedx Corrects Inaccuracies In MTF Press Release Regarding The Recent Rulings From The Patent Trial And Appeal Board 4State of Ohio and NineSigma Collaborate to Drive Regional Economic Growth and Job Creation 2State of Ohio and NineSigma Collaborate to Drive Regional Economic Growth and Job Creation 3
... N.J. , May 27 Tibotec Therapeutics, a ... launch of the HIV Case Manager Portal (the ... designed to help HIV/AIDS front-line service providers meet their daily ... in Denver, CO at the 22nd National Conference ...
... May 26 Results of clinical studies ... Staccato® loxapine (AZ-004) reduced agitation in patients, regardless of ... levels were observed as early as 10 minutes after ... by the Positive and Negative Syndrome Scale - Excited ...
Cached Medicine Technology:Tibotec Therapeutics Debuts Innovative Web Portal for HIV/AIDS Front-Line Service Providers 2Tibotec Therapeutics Debuts Innovative Web Portal for HIV/AIDS Front-Line Service Providers 3Tibotec Therapeutics Debuts Innovative Web Portal for HIV/AIDS Front-Line Service Providers 4Staccato(R) Loxapine (AZ-004) Reduced Signs and Symptoms of Agitation as Early as Ten Minutes After Dosing in Patients with Schizophrenia or Bipolar Disorder 2Staccato(R) Loxapine (AZ-004) Reduced Signs and Symptoms of Agitation as Early as Ten Minutes After Dosing in Patients with Schizophrenia or Bipolar Disorder 3Staccato(R) Loxapine (AZ-004) Reduced Signs and Symptoms of Agitation as Early as Ten Minutes After Dosing in Patients with Schizophrenia or Bipolar Disorder 4Staccato(R) Loxapine (AZ-004) Reduced Signs and Symptoms of Agitation as Early as Ten Minutes After Dosing in Patients with Schizophrenia or Bipolar Disorder 5Staccato(R) Loxapine (AZ-004) Reduced Signs and Symptoms of Agitation as Early as Ten Minutes After Dosing in Patients with Schizophrenia or Bipolar Disorder 6Staccato(R) Loxapine (AZ-004) Reduced Signs and Symptoms of Agitation as Early as Ten Minutes After Dosing in Patients with Schizophrenia or Bipolar Disorder 7Staccato(R) Loxapine (AZ-004) Reduced Signs and Symptoms of Agitation as Early as Ten Minutes After Dosing in Patients with Schizophrenia or Bipolar Disorder 8
(Date:8/28/2015)... ... August 28, 2015 , ... The Nashville Business Journal recently ... in business. Mr. Troy Mizell, Chairman of the Board at MyGenetx, is ... 2015 Veterans Awards will recognize Nashville military veterans who, through their professional and ...
(Date:8/28/2015)... , ... August 28, 2015 , ... Northridge dentists ... Zoom teeth whitening. For just $199, patients can currently receive a one hour treatment ... teeth whitening procedures, but it includes a number of unique features that can turn ...
(Date:8/28/2015)... Raleigh, NC (PRWEB) , ... August 28, 2015 , ... ... mesothelioma will not be available for general use any time soon, according to educational ... MTG-201, a biologic therapy that received orphan drug designation for mesothelioma last week from ...
(Date:8/28/2015)... MO (PRWEB) , ... August 28, 2015 , ... ... testosterone lawsuits now consolidated as MDL 2545, Testosterone Replacement Therapy Products ... a cap on the number of custodial files the PSC may receive for ...
(Date:8/28/2015)... ... August 28, 2015 , ... An independent ... result in high percentages of change to treatment recommendations and diagnosis. The 2015 ... at Tennessee Tech University and analyzed WorldCare’s second opinion process. , The study ...
Breaking Medicine News(10 mins):Health News:MyGenetx Board Member Receives Veterans Award 2Health News:Northridge Dentists Dr. Elyson and Dr. Assili Now Offer a Special Promotion on Zoom Teeth Whitening 2Health News:Surviving Mesothelioma Puts New Orphan Drug into Perspective in New Article 2Health News:National Testosterone Lawyers Provide Testosterone Lawsuit MDL Update 2Health News:National Testosterone Lawyers Provide Testosterone Lawsuit MDL Update 3Health News:National Testosterone Lawyers Provide Testosterone Lawsuit MDL Update 4Health News:WorldCare International, Inc. Celebrates Findings of Independent ROI Study 2
... do not get training posts through the flawed Medical ... the government// is stalling on a new contract for ... figures show that 34,250 doctors are chasing 18,500 specialist ... far given no commitment that trainee doctors will be ...
... promising anti-inflammatory drug failed to improve symptoms of moderate ... a large, multi-center trial. ,The results ... published in the first issue of the May American ... the American Thoracic Society. ,According to an ...
... a heart attack or severe chest pain today are much less ... even a few years ago, according to a new international study. ... a significant drop in the rate of heart failure and death ... ,The study finds that the change occurred at the same time ...
... war veterans who have come back after combat in the ... chemicals and other harmful substances, there is a decreased volume ... and memory. ,Roberta White, chair of the department ... Health, revealed, at the American Academy of Neurology's 59th Annual ...
... alert following a malaria epidemic that has claimed at ... ,"Doctors and paramedics have been put on alert ... out to vulnerable areas to check the spread of ... ,Eight of Assam's 29 districts have been ...
... immediately spot the victims of a bite from the Brazilian ... and an increase in blood pressure, they also sport an ... quest for more Viagras. Scientists say they have figured out ... boost. , “The erection is a side effect ...
Cached Medicine News:Health News:Junior Doctors Facing More Misery Because of Contract Deadlock: BMA 2Health News:Anti-inflammatory Drug Fails to Improve COPD Symptoms 2Health News:Good News for Sufferers of Heart Attack, Chest Pain 2Health News:Good News for Sufferers of Heart Attack, Chest Pain 3Health News:Good News for Sufferers of Heart Attack, Chest Pain 4Health News:Gulf War Veterans Exhibit Memory Impairment 2Health News:Malaria Claims 25 Lives in Assam 2Health News:Brazil Spider Offers Hope for Those Suffering from Erectile Dysfunction 2
Inquire...
Inquire...
Inquire...
The modular, high-end stereomicroscope; meets even the most critical demands in research and quality control provides high-contrast images with excellent depth of field and color fidelity...
Medicine Products: